BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37877357)

  • 1. N
    Lu J; Ru J; Chen Y; Ling Z; Liu H; Ding B; Jiang Y; Ma J; Zhang D; Ge J; Li Y; Sun F; Chen D; Zheng S; Wu J
    Clin Transl Med; 2023 Oct; 13(10):e1451. PubMed ID: 37877357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance.
    Wei W; Liu K; Huang X; Tian S; Wang H; Zhang C; Ye J; Dong Y; An Z; Ma X; Wang B; Huang Y; Zhang X
    J Exp Clin Cancer Res; 2024 Jan; 43(1):2. PubMed ID: 38163881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircSTX6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2.
    Meng L; Zhang Y; Wu P; Li D; Lu Y; Shen P; Yang T; Shi G; Chen Q; Yuan H; Ge W; Miao Y; Tu M; Jiang K
    Mol Cancer; 2022 Jun; 21(1):121. PubMed ID: 35650603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m
    Liu H; Jiang Y; Lu J; Peng C; Ling Z; Chen Y; Chen D; Tong R; Zheng S; Wu J
    Epigenetics; 2023 Dec; 18(1):2204772. PubMed ID: 37092305
    [No Abstract]   [Full Text] [Related]  

  • 5. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
    Gong J; Du C; Sun N; Xiao X; Wu H
    J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR-34c-5p/LGR4/β-catenin axis activity.
    Lyu LH; Zhang CY; Yang WJ; Jin AL; Zhu J; Wang H; Liu T; Wang BL; Cheng JW; Yang XR; Guo W
    J Cell Mol Med; 2022 Apr; 26(8):2218-2229. PubMed ID: 35170199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
    Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
    Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.
    Du A; Li S; Zhou Y; Disoma C; Liao Y; Zhang Y; Chen Z; Yang Q; Liu P; Liu S; Dong Z; Razzaq A; Tao S; Chen X; Liu Y; Xu L; Zhang Q; Li S; Peng J; Xia Z
    Mol Cancer; 2022 May; 21(1):109. PubMed ID: 35524319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 11. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma.
    Hu Z; Chen G; Zhao Y; Gao H; Li L; Yin Y; Jiang J; Wang L; Mang Y; Gao Y; Zhang S; Ran J; Li L
    Mol Cancer; 2023 Mar; 22(1):55. PubMed ID: 36932387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
    Li X; Shen M
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircGPR137B/miR-4739/FTO feedback loop suppresses tumorigenesis and metastasis of hepatocellular carcinoma.
    Liu L; Gu M; Ma J; Wang Y; Li M; Wang H; Yin X; Li X
    Mol Cancer; 2022 Jul; 21(1):149. PubMed ID: 35858900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis.
    Liu W; Yin C; Liu Y
    Cancer Biother Radiopharm; 2021 Dec; 36(10):863-878. PubMed ID: 32673066
    [No Abstract]   [Full Text] [Related]  

  • 15. EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathway.
    Liu Y; Song J; Zhang H; Liao Z; Liu F; Su C; Wang W; Han M; Zhang L; Zhu H; Zhang Z; Liang H; Zhang L; Zhang B; Chen X
    J Exp Clin Cancer Res; 2022 May; 41(1):164. PubMed ID: 35509064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circ_0001459 accelerates hepatocellular carcinoma progression via the miR-6165/IGF1R axis.
    Shen D; Zhao H; Zeng P; Ge M; Shrestha S; Zhao W
    Ann N Y Acad Sci; 2022 Jun; 1512(1):46-60. PubMed ID: 35199365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression.
    Chen C; Ge C; Liu Z; Li L; Zhao F; Tian H; Chen T; Li H; Yao M; Li J
    J Exp Clin Cancer Res; 2018 Oct; 37(1):263. PubMed ID: 30376856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway.
    Wang H; Zhang Q; Cui W; Li W; Zhang J
    Cell Cycle; 2021 Oct; 20(20):2125-2136. PubMed ID: 34570663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircCPSF6 promotes hepatocellular carcinoma cancer progression by regulating MAP4K4 through sponging miR-145-5p.
    Lu F; Gao J; Luo Y; Jin WL; Wang H; Li CX; Li X
    Mol Cell Probes; 2023 Oct; 71():101920. PubMed ID: 37442529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.
    Li R; Deng Y; Liang J; Hu Z; Li X; Liu H; Wang G; Fu B; Zhang T; Zhang Q; Yang Y; Chen G; Liu W
    Cell Oncol (Dordr); 2021 Apr; 44(2):279-295. PubMed ID: 33034848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.